ANZUPGO (DELGOCITINIB) — FDA Approval NDA219155 (LEO PHARMA AS)
ANZUPGO (DELGOCITINIB) — FDA Approval NDA219155 (LEO PHARMA AS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ANZUPGO; Active ingredients: DELGOCITINIB; Application number: NDA219155.
| Brand name | ANZUPGO |
|---|---|
| Active ingredients | DELGOCITINIB |
| Application number | NDA219155 |
| Sponsor | LEO PHARMA AS |
| Dosage form | CREAM |
| Route | TOPICAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20250723 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →